XML 79 R53.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) - USD ($)
$ in Millions
Jan. 31, 2022
Oct. 31, 2021
Cash Equivalents:    
Cost $ 1,974 $ 3,043
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,974 3,043
Available-for-Sale Investments:    
Cost 47 47
Gross Unrealized Gain 22 29
Gross Unrealized Loss 0 0
Fair Value 69 76
Total cash equivalents and available-for-sale investments, Cost 2,021 3,090
Total cash equivalents and available-for-sale investments, Gross Unrealized Gain 22 29
Total cash equivalents and available-for-sale investments, Gross Unrealized Loss 0 0
Total cash equivalents and available-for-sale investments, Fair Value 2,043 3,119
Corporate debt    
Cash Equivalents:    
Cost 1,047 1,112
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,047 1,112
Government debt    
Cash Equivalents:    
Cost 927 1,931
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 927 1,931
Financial institution instruments    
Available-for-Sale Investments:    
Debt securities, Cost 5 5
Debt securities, Gross Unrealized Gain 0 0
Debt securities, Gross Unrealized Loss 0 0
Debt securities, fair value 5 5
Marketable equity securities and mutual funds    
Available-for-Sale Investments:    
Equity securities, Cost 42 42
Equity securities, Gross Unrealized Gain 22 29
Equity securities, Gross Unrealized Loss 0 0
Equity securities, Fair Value $ 64 $ 71